Physician profile
Edward Martin
NPI 1982674719
$3,616.98
in general payments reported to CMS, 2019-2025
30 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $30.16 · 2021: $190 · 2022: $445 · 2023: $831 · 2024: $870 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,291.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $622.84 | 2019-2025 | |
| Boston Scientific Corporation | $216.80 | 2019-2025 | Watchman Flx, Watchman Access System |
| Merck Sharp & Dohme LLC | $211.83 | 2022-2025 | Verquvo, Belsomra, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $208.28 | 2019-2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $207.17 | 2023-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $195.88 | 2019-2025 | |
| Amgen INC. | $180.59 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $172.58 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $156.17 | 2019-2025 | |
| Esperion Therapeutics, INC. | $152.78 | 2023-2024 | Nexletol |
| Neosoft, LLC | $129.73 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.60 | 2019-2025 | Jardiance |
| Heartflow, INC. | $121.42 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.79 | 2019-2025 | Lifevest |
| Abiomed | $109.76 | 2024 | Impella |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $100.84 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Alnylam Pharmaceuticals INC. | $93.03 | 2023-2024 | Onpattro |
| Regeneron Healthcare Solutions, INC. | $85.15 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $74.53 | 2023-2024 | Inpefa |
| Philips North America LLC | $66.64 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $58.22 | 2021-2023 | Xarelto |
| Amarin Pharma, INC. | $56.16 | 2019 | |
| Siemens Medical Solutions USA, INC. | $26.04 | 2025 | Magnetom Sola |
| Gilead Sciences, INC. | $25.62 | 2019 | |
| Inspire Medical Systems, INC. | $21.88 | 2024 | Inspire |
| Nuwellis, INC. | $19.04 | 2020 | |
| Angiodynamics, INC. | $16.79 | 2019 | |
| Impulse Dynamics (USA) INC. | $15.92 | 2023 | Optimizer |
| Surmodics, INC. | $15.68 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Scpharmaceuticals INC. | $15.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.